These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20028826)

  • 1. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.
    Deyde VM; Sheu TG; Trujillo AA; Okomo-Adhiambo M; Garten R; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1102-10. PubMed ID: 20028826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
    Nakauchi M; Ujike M; Obuchi M; Takashita E; Takayama I; Ejima M; Oba K; Konomi N; Odagiri T; Tashiro M; Kageyama T;
    J Med Virol; 2011 Jul; 83(7):1121-7. PubMed ID: 21567417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
    Deyde VM; Nguyen T; Bright RA; Balish A; Shu B; Lindstrom S; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1039-47. PubMed ID: 19124660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
    Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
    Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
    J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.
    Deng YM; Caldwell N; Hurt A; Shaw T; Kelso A; Chidlow G; Williams S; Smith D; Barr I
    Antiviral Res; 2011 Apr; 90(1):87-91. PubMed ID: 21376084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
    Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
    Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory.
    Bao JR; Huard TK; Piscitelli AE; Tummala PR; Aleemi VE; Coon SL; Master RN; Lewinski MA; Clark RB
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):396-402. PubMed ID: 22000086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009.
    Zhou J; Zou L; Zhang X; Liao J; Ni H; Hou N; Wang Y; Li H; Wu J; Jonges M; Meijer A; Koopmans M; Ke C
    J Clin Microbiol; 2011 Jul; 49(7):2651-5. PubMed ID: 21593267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
    van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
    J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses.
    Carr MJ; Sayre N; Duffy M; Connell J; Hall WW
    J Virol Methods; 2008 Nov; 153(2):257-62. PubMed ID: 18718489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.